Gout Flashcards
Uricosuric drugs
Probenecid
Sulfinpyrazone
Lesinurad
Uricosuric drugs - Clinical use
Prevent gout attacks in persons who under-excrete uric acid.
Probenecid - MoA
Increases excretion of uric acid by competitive inhibition of uric acid reabsorption
Probenecid - Interactions
Aspirin and salicylates: interfere with the uricosuric effect.
High dose of salicylates: inh uric acid reabsorption
Low doses of salicylates: inh uric acid secretion
Sulfinpyrazone - MoA
Complete inhibition of urate reabsorption, increasing uric acid excretion
Sulfinpyrazone - Adverse
GI, renal and hematologic adverse effects
Lesinurad - MoA
Reduces uric acid levels by inh the function of transporters responsible for uric acid reabsorption, uric acid transporter 1 and organic anion transporter 4.
Xanthine oxidase inhibitors
Allopurinol
Febuxostat
Xanthine oxidase inhibitors - MoA
Decreases production of uric acid
Xanthine oxidase inhibitors - Clinical use
Prevent gout attacks in people who overproduce uric acid.
Prevent hyperuricemia and gout in persons having cancer chemotherapy and whose rate of purine catabolism is high.
Allopurinol - MoA
Competitive inhibitor of xanthine oxidase
Converted to active metabolite oxypurinol in the liver
Decrease in uric acid excretion and corresponding increase in urinary excretion of hypoxanthine.
Allopurinol - Clincal use
Hyperuricemia and gout in cancer patients with high purine catabolism
Prevent the occurrence or progression or both gouty arthritis and urate nephropathy
Tumor lysis syndrome
Lesch-Nyhan syndrome
Allopurinol - Adverse
Nausea, vomiting, hepatitis, skin rashes, hypersensitivity.
Steven-Johnson syndrome
Eosinophilia
DRESS syndrome
Allopurinol - Interactions
Inhibits catabolism of azathioprine and mercaptopurine
Febuxostat - MoA
Competitive inhibitor of xanthine oxidase